Vision Research (93.867)
Vision Research (Assistance Listing 93.867) is run by the National Institutes of Health, part of the Department of Health and Human Services. It awarded $3.4 billion in 3,275 grants from fiscal 2021 to 2025, about $1.0 million per award on average. 76 funding opportunities are open or forecast now.
The typical award was $752,554. Half of the 3,274 awards fell between $346,516 and $1.5 million, and they ranged from $0 to $33.2 million.
- Awarded, FY 2021 to 2025$3.4 billion
- Grant awards3,275
- Typical award$752,554
- Awarded in FY 2025$697 million
- Size rank118 of 1,823
- Type of assistanceProject grants
Key findings
- Annual funding rose from $643 million in fiscal 2021 to $697 million in fiscal 2025.
- It is the 118th largest of 1,823 federal grant programs by five-year awards.
- The 20 largest recipients received 40% of the money.
- Awards went to recipients in 47 states and territories.
What the program funds
The mission of the National Eye Institute is to eliminate vision loss and improve quality of life through vision research. The goal is to drive innovative research to understand the eye and visual system, prevent and treat vision diseases, and expand opportunities for people who are blind or require vision rehabilitation. Research grants and cooperative agreements 1) Support eye and vision research projects that address the leading causes of blindness and impaired vision in the U.S. These include, but are not limited to, retinal diseases; corneal diseases; cataract; glaucoma and optic neuropathies; strabismus; amblyopia; and low vision and blindness rehabilitation. 2) To increase understanding of the normal development and function of the visual system in order to better prevent, diagnose, and treat sight-threatening conditions; and, to enhance the rehabilitation, training, and quality of life of individuals who are partially-sighted or blind. 3) To encourage high quality clinical research, including clinical trials, other epidemiological studies, and health services research.
Open and forecast opportunities
- Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional)
- Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional)
- Competing Revisions to Existing NIH Single Project Research Grants and Cooperative Agreements (Clinical Trial Optional)
- Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed)
- NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed)
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
- HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)
- Biomedical Research Environment and Sponsored Programs Administration Development (BRE-SPAD) Program (UC2- Clinical Trial Not Allowed)
- BRAIN Initiative: Preclinical Proof of Concept for Novel Recording and Modulation Technologies in the Human CNS (R18 - Clinical Trial Not Allowed)
- BRAIN Initiative: Development and Validation of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in the Brain (R01 Clinical Trial Not Allowed)
- BRAIN Initiative: Exploratory Research Opportunities Using Invasive Neural Recording and Stimulating Technologies in the Human Brain (R61 Clinical Trial Not Allowed)
- NLM Institutional Grants for Research Training in Biomedical Informatics, Data Science, and AI (T15 Independent Clinical Trial Not Allowed)
- Discovery of in vivo Chemical Probes for the Nervous System (R01 Clinical Trial Not Allowed)
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
- NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)
- Mentored Quantitative Research Development Award (Parent K25 Independent Clinical Trial Not Allowed)
- NIH Pathway to Independence Award (Parent K99/R00 Independent Clinical Trial Not Allowed)
- Mentored Clinical Scientist Research Career Development Award (Parent K08 Independent Clinical Trial Not Allowed)
- BRAIN Initiative: Reagent Resources for Brain Cell Type-Specific Access to Broaden Distribution of Enabling Technologies for Neuroscience (U24 Clinical Trial Not Allowed)
- BRAIN Initiative: Brain Behavior Quantification and Synchronization- Next Generation Sensor Technology Development (U01 Clinical Trial Optional)
- Change of Recipient Organization (Type 7 Parent Clinical Trial Optional)
- Successor-in-Interest (Type 6 Parent Clinical Trial Optional)
- Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional)
- NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)
- Bioengineering Partnerships with Industry (U01 Clinical Trial Optional)
Rules from the program listing
Who can apply
Eligible organizations determined at the NOFO level.
What the money can and cannot pay for
Research Grants provide funds for salaries, equipment, supplies, travel, and other expenses associated with scientific investigation relevant to program objectives.
Matching requirements
This program has no statutory formula. Matching requirements are not applicable to this assistance listing. MOE requirements are not applicable to this assistance listing.
Award range and average, in the agency's words
FOR 2023: Research Grants (R): $12,400 to $2,178,277; Avg $422,981. Cooperative Agreements: $10,980 to $7,324,750; Avg $1,067,398. Centers (P): $400,718 to $949,680; Avg $677,851. K (Institutional): $183,986 to $545,160; Avg $454,904. K (Individual): $15,332 to $277,133; Avg $177,182. NRSA (Institutional): $28,815 to $272,894; Avg $142,678. NRSA (Individual): $2,500 to $78,552; Avg $47,548. SBIR Phase I: $54,475 to $350,075; Avg $270,429. SBIR Phase II: $245,829 to $1,907,135; Avg $768,574. STTR Phase I: $149,664 to $341,302; Avg $273,829. STTR Phase II: $289,895 to $537,483; Avg $402,459. SBIR/STTR Phase III: none. FOR 2024 YTD: Research Grants (R): $4,455 to $2,153,230; Avg $428,107. Cooperative Agreements: $81,518 to $8,942,823; Avg $1,283,922. Centers (P): $161,000 to $947,710; Avg $654,204. K (Institutional): $285,890 to $562,320; Avg $478,162. K (Individual): $21,767 to $280,704; Avg $175,903. NRSA (Institutional): $29,506 to $555,162; Avg $144,608. NRSA (Individual): $3,000 to $81,892; Avg $51,319. SBIR Phase I: $54,709 to $365,000; Avg $259,725. SBIR Phase II: $52,865 to $1,093,927; Avg $821,791. STTR Phase I: $180,642 to $180,642; Avg $180,642. STTR Phase II: $615,858 to $975,387; Avg $767,351. SBIR/STTR Phase III: none YTD.
Funding history and past recipients
From fiscal 2021 to 2025, Vision Research (93.867) awarded $3.4 billion across 3,275 grant awards, an average of $1.0 million per award.
Who usually wins
Colleges and universities received 76% of the money, nonprofits 17% and small businesses 3.8%.
| Recipient type | Awards | Amount | Share |
|---|---|---|---|
| Colleges and universities | 2,520 | $2.6 billion | 76% |
| Nonprofits | 479 | $578 million | 17% |
| Small businesses | 178 | $130 million | 3.8% |
| Other | 92 | $103 million | 3.0% |
| Businesses | 5 | $4.6 million | 0.1% |
| State and local governments | 1 | $446,433 | less than 0.1% |
By state
44 states have a page for this program: those that received at least $1 million or 10 awards.
| State | Awards | Amount |
|---|---|---|
| California | 586 | $598 million |
| New York | 310 | $327 million |
| Massachusetts | 305 | $313 million |
| Texas | 202 | $221 million |
| Pennsylvania | 145 | $188 million |
| Maryland | 174 | $166 million |
| Florida | 69 | $134 million |
| Illinois | 115 | $126 million |
| Ohio | 119 | $125 million |
| North Carolina | 125 | $118 million |
| Michigan | 98 | $109 million |
| Oregon | 88 | $85.4 million |
| Washington | 80 | $84.2 million |
| Wisconsin | 71 | $71.0 million |
| Tennessee | 72 | $69.1 million |
| Missouri | 63 | $62.0 million |
| Georgia | 72 | $58.8 million |
| Indiana | 53 | $55.7 million |
| Utah | 52 | $49.7 million |
| Connecticut | 54 | $44.6 million |
| Alabama | 47 | $43.0 million |
| Oklahoma | 36 | $33.5 million |
| Iowa | 38 | $32.6 million |
| Colorado | 32 | $28.9 million |
| Minnesota | 33 | $26.5 million |
| Virginia | 33 | $26.3 million |
| Kentucky | 25 | $21.6 million |
| Maine | 13 | $19.3 million |
| New Jersey | 15 | $18.3 million |
| West Virginia | 14 | $16.0 million |
| Arizona | 12 | $15.0 million |
| District of Columbia | 13 | $13.7 million |
| Rhode Island | 22 | $12.9 million |
| Delaware | 10 | $10.3 million |
| Louisiana | 14 | $9.1 million |
| South Carolina | 8 | $7.2 million |
| Nebraska | 9 | $7.1 million |
| New Hampshire | 6 | $6.6 million |
| New Mexico | 8 | $6.6 million |
| Nevada | 4 | $5.5 million |
| Idaho | 4 | $3.8 million |
| Arkansas | 5 | $2.5 million |
| Puerto Rico | 2 | $1.8 million |
| Mississippi | 3 | $1.3 million |
| Montana | 2 | $633,935 |
| Vermont | 2 | $467,616 |
| Kansas | 1 | $423,940 |